Literature DB >> 22503161

Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients.

Ebba Lohmann1, Rita J Guerreiro, Nihan Erginel-Unaltuna, Nicole Gurunlian, Basar Bilgic, Hakan Gurvit, Hasmet A Hanagasi, Nga Luu, Murat Emre, Andrew Singleton.   

Abstract

In order to assess the frequency of mutations in the known Alzheimer's disease causative genes in Turkish dementia patients we screened amyloid precursor protein (APP), PSEN1 and PSEN2 for mutations in a cohort of 98 Turkish dementia families. Six families were found to carry PSEN1 mutations (p.H163R, p.P264L, and p.H214Y) or variants suggested to cause the disease (p.L134R, p.L262V, and p.A396T). In 4 other families, previously reported PSEN2 variants were identified (p.R62H, p.R71W, p.M174V (n = 2), and p.S130L). The phenotype of the carriers varied from rapid progressing Alzheimer's disease to frontotemporal dementia, with spasticity and seizures also observed. Here we report a frequency of 11.2% of mutations and variants in the known Alzheimer disease genes in the dementia cohort studied and 24% in the early onset subgroup of patients, suggesting that mutations in these genes are not uncommon in Turkey and are associated with various phenotypes. We thus believe that genetic analysis should become a standardized diagnostic implement, not only for the identification of the genetic disease, but also for appropriate genetic counseling.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503161      PMCID: PMC4669567          DOI: 10.1016/j.neurobiolaging.2012.02.020

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  49 in total

1.  A presenilin 1 mutation in an early onset Alzheimer's family: no association with presenilin 2.

Authors:  S E Poduslo; K Herring; M Neal
Journal:  Neuroreport       Date:  1996-08-12       Impact factor: 1.837

2.  Familial Alzheimer's chromosome 14 mutations.

Authors:  W Wasco; W P Pettingell; P D Jondro; S D Schmidt; S Gurubhagavatula; L Rodes; T DiBlasi; D M Romano; S Y Guenette; D M Kovacs
Journal:  Nat Med       Date:  1995-09       Impact factor: 53.440

3.  Missense mutation of S182 gene in Japanese familial Alzheimer's disease.

Authors:  H Tanahashi; Y Mitsunaga; K Takahashi; H Tasaki; S Watanabe; T Tabira
Journal:  Lancet       Date:  1995-08-12       Impact factor: 79.321

4.  Mutation analysis of presenillin 1 gene in Alzheimer's disease.

Authors:  K Boteva; M Vitek; H Mitsuda; H de Silva; P T Xu; G Small; J R Gilbert
Journal:  Lancet       Date:  1996-01-13       Impact factor: 79.321

5.  Neuropathology of the recessive A673V APP mutation: Alzheimer disease with distinctive features.

Authors:  Giorgio Giaccone; Michela Morbin; Fabio Moda; Mario Botta; Giulia Mazzoleni; Andrea Uggetti; Marcella Catania; Maria Luisa Moro; Veronica Redaelli; Alberto Spagnoli; Roberta Simona Rossi; Mario Salmona; Giuseppe Di Fede; Fabrizio Tagliavini
Journal:  Acta Neuropathol       Date:  2010-09-15       Impact factor: 17.088

6.  Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patients.

Authors:  H Tanahashi; S Kawakatsu; M Kaneko; H Yamanaka; K Takahashi; T Tabira
Journal:  Neurosci Lett       Date:  1996-11-01       Impact factor: 3.046

7.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

8.  Mutations of the presenilin I gene in families with early-onset Alzheimer's disease.

Authors:  D Campion; J M Flaman; A Brice; D Hannequin; B Dubois; C Martin; V Moreau; F Charbonnier; O Didierjean; S Tardieu
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

9.  Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families.

Authors:  K Kamino; S Sato; Y Sakaki; A Yoshiiwa; Y Nishiwaki; M Takeda; H Tanabe; T Nishimura; K Ii; P H St George-Hyslop; T Miki; T Ogihara
Journal:  Neurosci Lett       Date:  1996-04-26       Impact factor: 3.046

10.  Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP.

Authors:  Rita Joao Guerreiro; Miquel Baquero; Rafael Blesa; Mercè Boada; Jose Miguel Brás; Maria J Bullido; Ana Calado; Richard Crook; Carla Ferreira; Ana Frank; Teresa Gómez-Isla; Isabel Hernández; Alberto Lleó; Alvaro Machado; Pablo Martínez-Lage; José Masdeu; Laura Molina-Porcel; José L Molinuevo; Pau Pastor; Jordi Pérez-Tur; Rute Relvas; Catarina Resende Oliveira; Maria Helena Ribeiro; Ekaterina Rogaeva; Alfredo Sa; Lluís Samaranch; Raquel Sánchez-Valle; Isabel Santana; Lluís Tàrraga; Fernando Valdivieso; Andrew Singleton; John Hardy; Jordi Clarimón
Journal:  Neurobiol Aging       Date:  2008-07-30       Impact factor: 4.673

View more
  15 in total

Review 1.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

2.  Diffuse Lewy Body Disease and Alzheimer Disease: Neuropathologic Phenotype Associated With the PSEN1 p.A396T Mutation.

Authors:  Dibson D Gondim; Adrian Oblak; Jill R Murrell; Rose Richardson; Francine Epperson; Owen A Ross; Bernardino Ghetti
Journal:  J Neuropathol Exp Neurol       Date:  2019-07-01       Impact factor: 3.685

Review 3.  Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders.

Authors:  Yan Cai; Seong Soo A An; SangYun Kim
Journal:  Clin Interv Aging       Date:  2015-07-14       Impact factor: 4.458

4.  Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients.

Authors:  Gamze Guven; Ebba Lohmann; Jose Bras; J Raphael Gibbs; Hakan Gurvit; Basar Bilgic; Hasmet Hanagasi; Patrizia Rizzu; Peter Heutink; Murat Emre; Nihan Erginel-Unaltuna; Walter Just; John Hardy; Andrew Singleton; Rita Guerreiro
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

5.  Identification of missing variants by combining multiple analytic pipelines.

Authors:  Yingxue Ren; Joseph S Reddy; Cyril Pottier; Vivekananda Sarangi; Shulan Tian; Jason P Sinnwell; Shannon K McDonnell; Joanna M Biernacka; Minerva M Carrasquillo; Owen A Ross; Nilüfer Ertekin-Taner; Rosa Rademakers; Matthew Hudson; Liudmila Sergeevna Mainzer; Yan W Asmann
Journal:  BMC Bioinformatics       Date:  2018-04-16       Impact factor: 3.169

6.  Discovery and validation of autosomal dominant Alzheimer's disease mutations.

Authors:  Simon Hsu; Brian A Gordon; Russ Hornbeck; Joanne B Norton; Denise Levitch; Adia Louden; Ellen Ziegemeier; Robert Laforce; Jasmeer Chhatwal; Gregory S Day; Eric McDade; John C Morris; Anne M Fagan; Tammie L S Benzinger; Alison M Goate; Carlos Cruchaga; Randall J Bateman; Celeste M Karch
Journal:  Alzheimers Res Ther       Date:  2018-07-18       Impact factor: 6.982

7.  The presenilin 1 P264L mutation presenting as non-fluent/agrammatic primary progressive aphasia.

Authors:  Colin J Mahoney; Laura E Downey; Jon Beck; Yuying Liang; Simon Mead; Richard J Perry; Jason D Warren
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

8.  Pleiotropic Effects of Variants in Dementia Genes in Parkinson Disease.

Authors:  Laura Ibanez; Umber Dube; Albert A Davis; Maria V Fernandez; John Budde; Breanna Cooper; Monica Diez-Fairen; Sara Ortega-Cubero; Pau Pastor; Joel S Perlmutter; Carlos Cruchaga; Bruno A Benitez
Journal:  Front Neurosci       Date:  2018-04-10       Impact factor: 4.677

9.  Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2.

Authors:  Simon Hsu; Anna A Pimenova; Kimberly Hayes; Juan A Villa; Matthew J Rosene; Madhavi Jere; Alison M Goate; Celeste M Karch
Journal:  Neurobiol Dis       Date:  2020-02-19       Impact factor: 5.996

10.  Human fibroblast and stem cell resource from the Dominantly Inherited Alzheimer Network.

Authors:  Celeste M Karch; Damián Hernández; Jen-Chyong Wang; Jacob Marsh; Alex W Hewitt; Simon Hsu; Joanne Norton; Denise Levitch; Tamara Donahue; Wendy Sigurdson; Bernardino Ghetti; Martin Farlow; Jasmeer Chhatwal; Sarah Berman; Carlos Cruchaga; John C Morris; Randall J Bateman; Alice Pébay; Alison M Goate
Journal:  Alzheimers Res Ther       Date:  2018-07-25       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.